Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2004Emerging infectious diseasesOpen Access

Quinolone-resistantCampylobacterInfections: Risk Factors and Clinical Consequences1

View Full Paper
Ask AI
Bookmark
Share

Authors

JEJørgen EngbergZealand University HospitalJNJ. NeimannENEva Møller NielsenStatens Serum Institut

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Engberg et al. (2004) studied this question.

synapsesocial.com/papers/6a937580b0cfcc27daff04e7https://doi.org/10.3201/eid1006.030669
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Use of Azithromycin for the Treatment of Campylobacter Enteritis in Travelers to Thailand, an Area Where Ciprofloxacin Resistance Is Prevalent1995 · 247 citations
  2. 2Antibiotic Resistance in <i>Campylobacter</i> Strains Isolated from Animals, Foods, and Humans in Spain in 1997–19982000 · 293 citations
  3. 3Norfloxacin resistance in Campylobacter jejuni and Campylobacter coli isolates from Swedish patients1997 · 46 citations
  4. 4Ciprofloxacin resistance in Campylobacter jejuni: case–case analysis as a tool for elucidating risks at home and abroad2002 · 64 citations
  5. 5Trends in Antibiotic Resistance Among Diarrheal Pathogens Isolated in Thailand Over 15 Years1998 · 380 citations